FN(FN)
FN
Q4 2026 EPS Estimate
$4.19
Nov 2, 2026 · Reports after close
Revenue Estimate
$1.40B
FY2027E EPS$18.20
FY2028E EPS$21.73
Analyst Sentiment
Wall St. Consensus
Buy22 analysts·High coverage
69
Score
17 Buy (77%)5 Hold (23%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1777%
Hold
523%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$739.00
+69.2%
Consensus
$769.50
+76.2%
Bull
$800.00
+83.2%
12-Month Target Range22 analysts
$739.00$769.50$800.00
Current $436.67Consensus
Current Price
$436.67
Upside to Consensus
$332.83
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+32.29%
EPS+31.52%
FY2028
Rev+19.42%
EPS+19.37%
FY2029
Rev+29.45%
EPS+34.76%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $6.09B | $7.27B | $9.41B |
| Low | $5.82B | $6.58B | $8.77B |
| High | $6.36B | $7.96B | $10.05B |
| EBITDA Avg | $716M | $855M | $1.11B |
| Low | $685M | $775M | $1.03B |
| High | $749M | $936M | $1.18B |
| EBIT Avg | $636M | $759M | $983M |
| Low | $608M | $687M | $915M |
| High | $664M | $831M | $1.05B |
| Net Income Avg | $663M | $794M | $1.03B |
| Low | $612M | $728M | $981M |
| High | $689M | $879M | $1.18B |
| EPS Avg | $18.20 | $21.73 | $29.28 |
| Low | $16.89 | $20.09 | $27.07 |
| High | $19.00 | $24.25 | $32.68 |
| Analysts (Rev / EPS) | 5 / 4 | 5 / 3 | 2 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $1.40B | $1.48B | $1.56B | $1.65B | $1.65B | $1.71B | $1.78B | $1.86B |
| Low | $1.39B | $1.45B | $1.54B | $1.63B | $1.63B | $1.69B | $1.76B | $1.83B |
| High | $1.42B | $1.51B | $1.59B | $1.68B | $1.68B | $1.74B | $1.81B | $1.89B |
| EBITDA Avg | $165M | $174M | $183M | $195M | $194M | $201M | $209M | $218M |
| Low | $163M | $170M | $181M | $192M | $192M | $199M | $207M | $216M |
| High | $167M | $177M | $187M | $198M | $198M | $205M | $213M | $223M |
| EBIT Avg | $146M | $154M | $163M | $173M | $173M | $179M | $186M | $194M |
| Low | $145M | $151M | $161M | $171M | $171M | $177M | $184M | $192M |
| High | $149M | $157M | $166M | $176M | $176M | $182M | $189M | $197M |
| Net Income Avg | $152M | $160M | $169M | $179M | $181M | $188M | $197M | $208M |
| Low | $148M | $153M | $166M | $177M | $179M | $185M | $194M | $204M |
| High | $154M | $166M | $173M | $184M | $186M | $193M | $202M | $213M |
| EPS Avg | $4.19 | $4.42 | $4.66 | $4.95 | $5.00 | $5.19 | $5.45 | $5.73 |
| Low | $4.09 | $4.23 | $4.59 | $4.87 | $4.93 | $5.11 | $5.36 | $5.64 |
| High | $4.24 | $4.58 | $4.77 | $5.07 | $5.12 | $5.31 | $5.58 | $5.87 |
| Analysts (Rev / EPS) | 5 / 6 | 5 / 6 | 2 / 2 | 2 / 2 | 2 / 2 | 2 / 2 | 1 / 3 | 1 / 3 |